Richard A. Gonzalez - Jul 17, 2024 Form 4 Insider Report for AbbVie Inc. (ABBV)

Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Richard A. Gonzalez
Stock symbol
ABBV
Transactions as of
Jul 17, 2024
Transactions value $
-$27,578,827
Form type
4
Date filed
7/19/2024, 04:40 PM
Previous filing
Jul 2, 2024
Next filing
Aug 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Options Exercise $5.34M +87.1K +16.97% $61.36* 600K Jul 17, 2024 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $9.44M +119K +19.9% $79.02* 720K Jul 17, 2024 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $7.14M +76.4K +10.61% $93.50 796K Jul 17, 2024 Direct
transaction ABBV Common Stock, $0.01 par value Sale -$49.5M -283K -35.54% $175.00 513K Jul 17, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Option (Right To Buy) Options Exercise $0 -87.1K -100% $0.00* 0 Jul 17, 2024 Common Stock 87.1K $61.36 Direct F1
transaction ABBV Option (Right To Buy) Options Exercise $0 -119K -66.67% $0.00 59.7K Jul 17, 2024 Common Stock 119K $79.02 Direct F1
transaction ABBV Option (Right To Buy) Options Exercise $0 -76.4K -33.33% $0.00 153K Jul 17, 2024 Common Stock 76.4K $93.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).